HemoSonics Quantra QPlus system gets de novo clearance

Create PDF

“The Quantra Hemostasis Analyzer is revolutionary and a dramatic improvement over existing tools,” Danja Groves, MD, PhD, an anesthesiologist in Charlottesville, Va., said in a press release from HemoSonics. “Using the Quantra, clinicians have information that was previously unavailable in a time frame that enables proactive bleeding management. This is a game-changer for transfusion management.”

The company’s patented SEER sonorheometry ultrasound technology provides fully automated testing in a closed system. It also introduces unique parameters, the company says, which assess platelet contribution to clot stiffness and the likelihood of residual heparin in the sample.